Dan XUE (薛丹) , Rong-lin LAN (蓝荣林) , Hua-tao HU (胡华涛) , Yun-bin ZHANG (张云彬) , Xian-bao HUANG (黄仙保)
{"title":"Moxibustion for chemotherapy-induced myelosuppression: A systematic review and meta-analysis","authors":"Dan XUE (薛丹) , Rong-lin LAN (蓝荣林) , Hua-tao HU (胡华涛) , Yun-bin ZHANG (张云彬) , Xian-bao HUANG (黄仙保)","doi":"10.1016/j.wjam.2025.12.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the effectiveness and safety of moxibustion for chemotherapy-induced myelosuppression.</div></div><div><h3>Methods</h3><div>The randomized controlled trials of moxibustion for chemotherapy-induced myelosuppression were searched in PubMed, Cochrane Library, Web of Science, Embase, China Journal Full-text Database, SinoMed, Wanfang Data Knowledge Service Platform, and VIP Chinese Journal Service Platform, from the inception of each database to July 30, 2024. RevMan5.3 and Stata18.0 were used for meta-analysis, and the quality of included literature was evaluated by Cochrane Risk of Bias (RoB) assessment tool.</div></div><div><h3>Results</h3><div>A total of 19 articles were included. Moxibustion can increase white blood cell count (MD = 1.06, 95 % CI: 0.45–1.68, <em>P</em> = 0.0007), platelet count (MD = 32.02, 95 % CI: 16.33–47.72, <em>P</em> < 0.00001), hemoglobin content (MD = 5.57, 95 % CI: 1.61–9.53, <em>P</em> = 0.006) and neutrophil count (MD = 1.20, 95 % CI: 0.94–1.45, <em>P</em> < 0.00001). Moxibustion could alleviate chemotherapy-induced myelosuppression (RR = 0.70, 95 % CI: 0.56–0.86, <em>P</em> = 0.0007), reduced the incidences of leukopenia (RR = 0.39, 95 % CI: 0.26–0.59, <em>P</em> < 0.000001) and thrombocytopenia (RR = 0.33, 95 % CI: 0.21–0.53, <em>P</em> < 0.000001), and can improve the score of quality of life (MD = 0.55, 95 % CI: 0.32–0.79, <em>P</em> < 0.00001).</div></div><div><h3>Conclusion</h3><div>Moxibustion can increase the white blood cell count, platelet count, hemoglobin content and neutrophil count of patients after chemotherapy, alleviate myelosuppression, and the incidences of leukopenia and thrombocytopenia induced by chemotherapy, and improve the quality of life. Moxibustion is effective and safe for chemotherapy-induced myelosuppression. However, due to the relatively low quality of included studies, there are certain limitations. More high-quality studies are needed in the future to provide more reliable evidence-based basis for clinical practice.</div></div>","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"36 1","pages":"Pages 18-28"},"PeriodicalIF":1.3000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Acupuncture-Moxibustion","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1003525725000984","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/11 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To evaluate the effectiveness and safety of moxibustion for chemotherapy-induced myelosuppression.
Methods
The randomized controlled trials of moxibustion for chemotherapy-induced myelosuppression were searched in PubMed, Cochrane Library, Web of Science, Embase, China Journal Full-text Database, SinoMed, Wanfang Data Knowledge Service Platform, and VIP Chinese Journal Service Platform, from the inception of each database to July 30, 2024. RevMan5.3 and Stata18.0 were used for meta-analysis, and the quality of included literature was evaluated by Cochrane Risk of Bias (RoB) assessment tool.
Results
A total of 19 articles were included. Moxibustion can increase white blood cell count (MD = 1.06, 95 % CI: 0.45–1.68, P = 0.0007), platelet count (MD = 32.02, 95 % CI: 16.33–47.72, P < 0.00001), hemoglobin content (MD = 5.57, 95 % CI: 1.61–9.53, P = 0.006) and neutrophil count (MD = 1.20, 95 % CI: 0.94–1.45, P < 0.00001). Moxibustion could alleviate chemotherapy-induced myelosuppression (RR = 0.70, 95 % CI: 0.56–0.86, P = 0.0007), reduced the incidences of leukopenia (RR = 0.39, 95 % CI: 0.26–0.59, P < 0.000001) and thrombocytopenia (RR = 0.33, 95 % CI: 0.21–0.53, P < 0.000001), and can improve the score of quality of life (MD = 0.55, 95 % CI: 0.32–0.79, P < 0.00001).
Conclusion
Moxibustion can increase the white blood cell count, platelet count, hemoglobin content and neutrophil count of patients after chemotherapy, alleviate myelosuppression, and the incidences of leukopenia and thrombocytopenia induced by chemotherapy, and improve the quality of life. Moxibustion is effective and safe for chemotherapy-induced myelosuppression. However, due to the relatively low quality of included studies, there are certain limitations. More high-quality studies are needed in the future to provide more reliable evidence-based basis for clinical practice.
期刊介绍:
The focus of the journal includes, but is not confined to, clinical research, summaries of clinical experiences, experimental research and clinical reports on needling techniques, moxibustion techniques, acupuncture analgesia and acupuncture anesthesia.